Clinical Trial Disclosure: More “FDA” Needed in Past and Present Acts
Federal mandates calling for transparency of clinical trial information have been in place in the United States since 1997, but a recent move will finally give the current…
RESOURCES
Transparent Thinking.
Working notes on clinical trial transparency since 2012 — disclosure, anonymization, and AI-assisted writing, by the people who do the work.
Clinical Disclosure Reporting: Are You Prepared to Meet the Expanding Requirements?
A group of House Democrats led by Congressman Edward Markey (D-Mass.) on Aug. 2, 2012 introduced the Trial and Experimental Studies Transparency (TEST) Act of 2012 (H.R. 6272),…